Gemifloxacin long-term outcomes in bronchitis exacerbations (GLOBE) study - An assessment of health outcome benefits in aecb patients following 5 days' gemifloxacin (GEMI) therapy
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- June 1, 2001
has subject area
- 0605 Microbiology (FoR)
- 1108 Medical Microbiology (FoR)
- 1115 Pharmacology and Pharmaceutical Sciences (FoR)
- Microbiology (Science Metrix)